Biological Therapy Analysis & Statistics, March 2011 (p10)

International Stem Cell Corporation-Detailed Product Pipeline

$ 750
Company report
March 2011
by Life Science Analytics (LSA)

International Stem Cell Corporation-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances ...

Industries : Biological Therapy

Stem Cell Innovations Inc-Deals & Alliances Report

$ 600
Company report
March 2011
by Life Science Analytics (LSA)

Stem Cell Innovations Inc-Deals & Alliances ReportReport contains the company's contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category ...

Industries : Biological Therapy

Cytokine PharmaSciences Inc.-Detailed Product Pipeline

$ 750
Company report
March 2011
by Life Science Analytics (LSA)

Cytokine PharmaSciences Inc.-Detailed Product Pipeline provides up to date insight into company's business description, product information, pipeline details including both summary information and detailed ...

Industries : Biological Therapy
Countries : World

Bioheart, Inc.-Therapeutic Competitors

$ 350
Company report
March 2011
by Life Science Analytics (LSA)

Bioheart, Inc.-Therapeutic Competitors Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products listed with ...

Industries : Biological Therapy

International Stem Cell Corporation-Therapeutic Competitors

$ 350
Company report
March 2011
by Life Science Analytics (LSA)

International Stem Cell Corporation-Therapeutic Competitors Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company ...

Industries : Biological Therapy

International Stem Cell Corporation-Deals & Alliances Report

$ 600
Company report
March 2011
by Life Science Analytics (LSA)

International Stem Cell Corporation-Deals & Alliances ReportReport contains the company's contact information, business summary, company details, tables, graphs and listings of the number of deals by deal ...

Industries : Biological Therapy

Antisense Pharma GmbH-Therapeutic Competitors Report

$ 350
Company report
March 2011
by Life Science Analytics (LSA)

Antisense Pharma GmbH-Therapeutic Competitors Report Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products ...

Industries : Biological Therapy

Bioheart, Inc.-Deals & Alliances Report

$ 600
Company report
March 2011
by Life Science Analytics (LSA)

Bioheart, Inc.-Deals & Alliances ReportReport contains the company's contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category (product, ...

Industries : Biological Therapy

Antisense Pharma GmbH-Detailed Product Pipeline

$ 750
Company report
March 2011
by Life Science Analytics (LSA)

Antisense Pharma GmbH-Detailed Product Pipeline provides up to date insight into company's business description, product information, pipeline details including both summary information and detailed individual ...

Industries : Biological Therapy
Countries : World

Cytokine PharmaSciences Inc.-Deals & Alliances Report

$ 600
Company report
March 2011
by Life Science Analytics (LSA)

Cytokine PharmaSciences Inc.-Deals & Alliances ReportReport contains the company's contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category ...

Industries : Biological Therapy

IBt (International Brachytherapy) s.a-Deals & Alliances Report

$ 600
Company report
March 2011
by Life Science Analytics (LSA)

IBt (International Brachytherapy) s.a-Deals & Alliances ReportReport contains the company's contact information, business summary, company details, tables, graphs and listings of the number of deals by ...

Industries : Biological Therapy

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Takara Bio Inc. (4974)

$ 250
Company report
March 2011
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biological Therapy
Countries : United States

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: StemCells, Inc. (STEM)

$ 250
Company report
March 2011
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biological Therapy
Countries : United States

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: MEDINET Co., Ltd. (2370)

$ 250
Company report
March 2011
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biological Therapy

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Tocagen Inc

$ 250
Company report
March 2011
by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Industries : Biological Therapy
Countries : United States

Research Case : Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-development

$ 1 900
Industry report
March 2011
by Datamonitor

About This Report The treatment of cancer has seen a dramatic shift with the addition of molecular targeted therapies. The mixed and unpredictable responses to these targeted therapies are driving the ...

Industries : Biological Therapy
Countries : Japan, United States

Stem Cell Therapeutics for Oncology: Technologies and Global Markets

$ 5 450
Industry report
March 2011
by BCC Research

The global stem cell anticancer therapeutics market was valued at $859 million in 2010. This market is expected to increase at an 11.3% compound annual growth rate (CAGR) to reach nearly $1.5 billion in ...

Industries : Biological Therapy
Countries : World

Future Directions in Regenerative Medicine

$ 3 835
Industry report
February 2011
by SCRIP Insights

Big Pharma has begun investing in regenerative medicine: Genzyme in 2008, Pfizer and Novartis in 2009, and Cephalon in 2010. In 3-5 years, investment will reach a ?tipping point?, after which no medical ...

Industries : Biological Therapy
Countries : United States

Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market

$ 3 500
Industry report
February 2011
by GBI Research

Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market Summary GBI Research, the leading business intelligence provider, has released its latest research ?Targeted ...

Industries : Biological Therapy
Countries : World

US Stem Cells Research Industry

$ 4 500
Industry report
February 2011
by Global Industry Analyst

This report analyzes the US Market for Stem Cells Research in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The report profiles 92 companies including many key and niche ...

Industries : Biological Therapy
Countries : United States

World Biological Therapy: Natural Killer Cell Lymphomas - Pipeline Review, Q1 2011

$ 500
Company report
January 2011
by Global Markets Direct

This report provides data on the therapeutic development for Natural Killer Cell Lymphomas, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

Industries : Biological Therapy, Healthcare, Pharmaceutical
Countries : World

Competitor Analysis G-CSF & GM-CSF

$ 452
Industry report
January 2011
by La Merie Publishing

Product description The present Competitive Intelligence Report about G-CSF & GM-CSF products in the pipeline and off-patent products provides a competitor evaluation in the field of G-CSF & GM-CSF branded ...

Industries : Biological Therapy

Looking at the Cancer Therapy Market

$ 250
Industry report
January 2011
by Aruvian's R'search

Cancer is a disease characterized by a population of cells that grow and divide without respect to normal limits, invade and destroy adjacent tissues, and may spread to distant anatomic sites through a ...

Industries : Biological Therapy
Countries : World

Biopharmaceutical Industry: Acromegaly And Gigantism (Growth Hormone Disorders) - Pipeline Review, Q4 2010

$ 500
Company report
December 2010
by Global Markets Direct

This report provides data on the therapeutic development for Acromegaly and Gigantism , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

Industries : Biological Therapy
Countries : Israel, World

Biological Therapy Industry: Grupo Espanol de Linfoma y Trasplante de Medula Osea - Developmental Therapeutics Review - Q4 2010

$ 500
Industry report
December 2010
by Global Markets Direct

The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced ...

Industries : Biological Therapy
Countries : World

Talecris Biotherapeutics Holdings Corp SWOT

$ 175
Company report
December 2010
by MarketLine

examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Talecris Biotherapeutics Holdings (Talecris) is one ...

Industries : Biological Therapy
Countries : United States, Canada

Biological Therapy: Stem Cell Therapy Holds Promise for Ischemic Heart Disease Patients

$ 500
Company report
November 2010
by Global Data

What's inside this report? Industry expert's report, ?? provides key data, data on the scope of Stem Cell Therapy in cardiovascular disease. Research Scope - Data and data on the most commonly reprocessed ...

Industries : Biological Therapy
Countries : United States

Biological Therapy Industry: Bioheart, Inc. - Product Pipeline Review - Q4 2010

$ 500
Company report
November 2010
by Global Markets Direct

? Product Pipeline Review - Q4 2010 pharmaceuticals report, ?? provides a detailed overview on the firm ?s research and development focus. The report includes data on current developmental pipeline, complete ...

Industries : Biological Therapy
Countries : World

Amgen: Pipeline - Products ? Performance - Potential

$ 1 041
Company report
November 2010
by Espicom Business Intelligence

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance ...

Industries : Biological Therapy
Countries : United States, Europe, Australia

Drug Discovery and Development Industry: Antisense Pharma GmbH - Product Pipeline Review - Q4 2010

$ 500
Company report
November 2010
by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. It also gives a complete picture of the firm ?s future therapy ...

Industries : Biological Therapy
Countries : World